December 6, 2007
Deal Could Improve Drug Manufacturing
By Matthew L. Brown
Billerica-based Millipore Corp. and Rohm and Haas Co., a Philadelphia-based company with about 600 employees in Marlborough, North Andover and Woburn, announced a joint development agreement to create new high-performance chromatography products that are used to manufacture biologic drugs.
The companies said the agreement would allow the combination of Millipore's biopharmaceutical manufacturing expertise with Rohm and Haas' knowledge of ion exchange resins and polymer chemistry.
Ion exchange is used to separate molecules based on their molecular charge and is a critical step in purifying biologic drugs.
The companies said the agreement would allow the combination of Millipore's biopharmaceutical manufacturing expertise with Rohm and Haas' knowledge of ion exchange resins and polymer chemistry.
Ion exchange is used to separate molecules based on their molecular charge and is a critical step in purifying biologic drugs.
WBJ Web Partners
Most Recent
Most Recent
0 Comments